Hexarelin

A synthetic hexapeptide growth-hormone releasing peptide, one of the original GHRPs and the strongest of the family for peak GH output. Like ipamorelin, hexarelin is a ghrelin-receptor agonist, a secretagogue that tells your pituitary to fire a GH pulse. The difference is selectivity: ipamorelin triggers the pulse and leaves everything else alone, while hexarelin drags cortisol, prolactin, and ACTH up with it. That tradeoff, more GH but more noise, defines hexarelin.

It also binds CD36, a scavenger receptor on heart tissue, a separate mechanism from the GH pathway. That cardiac angle drew research interest, but it is not why people run it. People run hexarelin for the GH burst, paired with a GHRH analog like CJC-1295 the same way they pair ipamorelin.

Small human studies, mostly endocrine challenge work, showing potency and the tradeoffs that come with it:

Short cycles, not a daily-driver compound. The desensitization data tells the story: run hexarelin for more than a few weeks and the GH response fades. The community pattern is four to eight weeks on, then an equal or longer break to let the receptor recover. Pin it subcutaneously on an empty stomach, same timing rules as ipamorelin, because food blunts the pulse.

Most people run hexarelin alongside a GHRH analog so the pituitary is primed when hexarelin fires. Pre-bed is the common anchor dose, riding the natural overnight GH window, but the same sleep study that documented the hormone profile found reduced deep sleep and lower delta power after nocturnal dosing. If sleep quality matters, and it should, a morning or post-training dose may be the better anchor. Dose higher than 200 mcg per shot and you are mostly buying more cortisol and prolactin, not more GH, since the GH response plateaus while the sides keep climbing.

Stronger GH pulse, louder side profile. That is the deal: